| 摘要 |
The present invention concerns methods and tools for determining a specific treatment of a prolactin associated disorder. The treatment is selected based on the expression pattern of growth hormonereceptor(GHR), prolactin receptor (PrlR) and the suppressors SOCS2 and TCS2. |
